Medicines and Therapies

Pharmac says people with type 2 diabetes won’t be made to pay for alternative medicines

Amanda Cameron explores the latest clinical work under way at Douglas Pharmaceuticals which has just opened a new innovation wing

This article is the first in a three-part series designed to highlight the role pharmacists can play in reducing “the pill burden” in our society, writes Katrina Azer, clinical pharmacist at Tend Health. The articles will focus on polypharmacy, deprescribing and social prescribing, with the patient’s perspective front of mind

Australian GP Jonathan Bentley shares a case study in which a war is waged and won against hair loss, and against the mood disorder that accompanied treatment

New medicines for those with a rare spinal disease and people at risk of anaphylaxis are set to be publicly funded

Zematane has been approved to be prescribed in New Zealand to patients who suffer from severe, chronic hand eczema. The active substance in Zematane capsules is alitretinoin

An 89-year-old woman who was prescribed Paxlovid despite having a contraindication for the COVID-19 antiviral collapsed four days later and was taken to hospital

Jonathan Chilton-Towle reports on a burgeoning pharmacy service for patients with a common sleep disorder

Despite CPAMS being the most effective way to manage warfarin patients, expansion of the pharmacy-run service looks unlikely, Paulette Crowley writes

Despite CPAMS being the most effective way to manage warfarin patients, expansion of the pharmacy-run service looks unlikely, Paulette Crowley writes